retatrutide phase 2 nejm 2023 percent weight loss 48 weeks Peptide Series #3 — 🧬🏃🏻‍♀️ BOOM🔥! The most POWERFUL DRUG EVER tested in a clinical trial isn't approved yet. But the data is already rewriting what we thought was Retatrutide hits 28% weight loss

This is consistent with GHK-Cus known role in upregulating collagen synthesis in dermal fibroblasts, a mechanism confirmed in a comprehensive review in Biomolecules documenting GHK-Cus influence across more than 4,000 human genes involved in tissue remodeling and repair

and limiting plaque thickening and rupture, atherosclerosis is inhibited

However, questions persist about its effects on thyroid function and overall hormonal balance, particularly for patients with existing thyroid conditions

Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers

By combining doctor supervision, affordable compounded GLP-1 medications, and telehealth convenience , it stands at the forefront of healthcare innovation in 2025